drugset
drugset / Trial / NCT05614544

Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

NCT05614544 ↗

Phase 1 Completed 42 enrolled Haisco-USA Pharmaceuticals, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Part 1: To determine the doses of IV HSK3486 and propofol for use in Part 2, the abuse potential part of the study. Part 2: To evaluate the abuse potential of HSK3486 compared with propofol when administered IV to healthy nondependent, recreational CNS depressant drug users.

Timeline

Start
2022-08-16
Primary completion
2023-10-03
Completion
2023-10-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule — Intravenous
Comparator Propofol Small molecule — Intravenous

Indications

No indication recorded.